February 2013


In this Issue


Past • Present • Future



Guest Chief Medical Editors’ Page

EVAR’s Continued Progress and Questions on the Horizon

By Ronald M. Fairman, MD, and Edward Y. Woo, MD

Cover Stories

Updating Our Understanding of EVAR

Have the results shown a significant improvement in outcomes with a new generation of devices?

By Frederico Bastos Gonçalves, MD; Sander ten Raa, MD, PhD; Daniël Eefting, MD, PhD; Ellen V. Rouwet, MD, PhD; Johanna M. Hendriks, MD, PhD; and Hence J. M. Verhagen, MD, PhD

Lessons Learned in Offering EVAR for Ruptured Aneurysms

Important considerations to improve outcomes.

By Manish Mehta, MD, MPH, and Jeffrey C. Hnath, MD

Early Detection of Type I Endoleaks

How we diagnose and treat type I endoleaks by careful evaluation of patients, devices, and imaging modalities.

By Benjamin Colvard, MD, and Jason T. Lee, MD

Managing Type II Endoleaks

Although a common complication, type II endoleaks are not always benign and require innovative treatment strategies.

By Naveed U. Saqib, MD; Kristofer M. Charlton-Ouw, MD; and Ali Azizzadeh, MD, FACS

Standard EVAR for the 10-mm Neck

A comprehensive strategy composed of the essential experience and technology needed to achieve satisfactory outcomes when treating short-necked aneurysms.

By Amir H. Malkawi, MD, FRCS; Matt M. Thompson, MD, FRCS; and Ian M. Loftus, MD, FRCS

What Is the Future of EVAR With Health Care Reform?

Declining reimbursement may affect this procedure and the medical device industry.

By Sean P. Lyden, MD

Ask The Experts

What Is Your Preferred EVAR Device and Why?

By Michael J. Singh, MD, FACS, RPVI; Sharif Ellozy, MD; Mark K. Eskandari, MD, FACS; Ross Milner, MD; Ronald M. Fairman, MD; and Peter R. Nelson, MD, MS

How Has Your Practice Changed With the Availability of Fenestrated Devices?

By Thomas S. Maldonado, MD, FACS; Luis A. Sanchez, MD, FACS; Edward Y. Woo, MD; and Mark Farber, MD

Vessel Update: SFA

Bioresorbable Vascular Scaffolds: Progress and Potential

Koen Deloose, MD, discusses the potential advantages of this technology, results to date, and remaining questions to be answered.



An Interview With A. Ross Naylor, MD

The recipient of the Gore & Associates 2012 Dedication to Analysis of Clinical Outcomes Award shares his perspective on the current assessment, treatment protocols, and clinical research for patients with carotid artery disease.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.